O’Brien, M. JM., Wallis, A. K., Heerey, J. J.
, Tønning, L. U., Mechlenburg, I., Jacobsen, J. S. S., Balakumar, J. & Kemp, J. L. (2025).
Athletes with hip dysplasia: current understanding, management and future directions.
British Journal of Sports Medicine,
59(13), 887-889.
https://doi.org/10.1136/bjsports-2024-108777Ma, J., Bechsgaard, J. S., Lauridsen, A. A., Villesen, P., Bilde, T. & Schierup, M. H. (2025).
The genomic consequences and persistence of sociality in spiders.
Genome Research,
35(3), 499-511.
https://doi.org/10.1101/gr.279503.124
Thielscher, A.
, Weise, K. F., Madsen, K. H., Knösche, T. R., Worbs, T.
& Korshoej, A. R. (2025).
A flexible optimization framework for transcranial electric stimulation, temporal interference stimulation and tumor treating fields.
Brain Stimulation,
Vol. 18(Issue 1), 294. Article Volume 18, Issue 1.
https://doi.org/10.1016/j.brs.2024.12.239Lemvik, G., Larsson, L.
, Rudolf, F., Vejrum, J. E., Sodemann, M., Gomes, V. F.
& Wejse, C. (2025).
An open-label cluster-randomised trial on TB preventive therapy for children.
IJTLD Open,
2(3), 120-128.
https://doi.org/10.5588/ijtldopen.24.0467
Rønnstad, A. T. M., Bunick, C. G., Chovatiya, R., Kamata, M., Nielsen, M.-L., Isufi, D., Thomsen, S. F.
, Vestergaard, C., Wollenberg, A., Egeberg, A., Thyssen, J. P. & Loft, N. (2025).
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis.
American Journal of Clinical Dermatology,
26(3), 411-424. Article s318.
https://doi.org/10.1007/s40257-025-00927-xSieborg, J., Maul, J.-T., Wu, J. J., Loft, N. N., Skov, L., Bryld, L. E.
, Rasmussen, M. K., Dam, T. N., Bertelsen, T., Ajgeiy, K. K., Thomsen, S. F., Thyssen, J. P., Egeberg, A. & Thein, D. (2025).
Real-world Drug Survival of Biosimilar SB5 vs GP2017 Following a Mandatory Non-medical Switch from Adalimumab Originator for Psoriasis: A Nationwide Cohort Study.
Acta Dermato-Venereologica,
105, Article adv42572.
https://doi.org/10.2340/actadv.v105.42572Cork, M. J.
, Deleuran, M., Geng, B., Silverberg, J. I., Simpson, E. L., Stein Gold, L. F., Irvine, A. D., Romero, W., Valdez, H., Fan, H. & Alderfer, J. (2025).
Long-Term Safety of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: Integrated Analysis by Age.
The Journal of Allergy and Clinical Immunology: In Practice,
13(5), 1164-1175.e2.
https://doi.org/10.1016/j.jaip.2025.02.040Skovsgård, C. H., Frølunde, A. S., Deleuran, M., Thyssen, J. P., Thomsen, S. F.
& Vestergaard, C. (2025).
Counselling Needs in Atopic Dermatitis: Perspectives on Pregnancy and Treatment.
Acta Dermato-Venereologica,
105, Article adv42544.
https://doi.org/10.2340/actadv.v105.42544